Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marta C. Nunes"'
Autor:
Shabir A. Madhi, Marta C. Nunes, Omphile E. Simani, Avy Violari, Alane Izu, Nadia van Niekerk, Peter V. Adrian, Mark F. Cotton
Publikováno v:
Expert Review of Vaccines. 18:95-104
Objectives: We evaluated memory responses and antibody persistence to diphtheria-toxoid, tetanus-toxoid, whole-cell-pertussis (DTwP), and Hepatitis-B vaccines in HIV-unexposed, HIV-exposed-uninfected and HIV-infected children previously randomized to
Autor:
Shabir A. Madhi, Marta C. Nunes
Publikováno v:
Human Vaccines & Immunotherapeutics. 12:314-325
The introduction of pneumococcal conjugate vaccine (PCV) into the South African public immunization program since 2009 adopted a novel vaccination schedule of 3 doses at 6, 14 and 40 weeks of age. Over the past 5 y it has been shown that infant PCV i
Autor:
Marta C. Nunes, Shabir A. Madhi
Publikováno v:
Human Vaccines & Immunotherapeutics. 11:2538-2548
Pregnant women are considered to be susceptible to severe influenza illness and are recommended as a priority group to be targeted for influenza vaccination in countries with vaccination programs. Increased rates of poor birth outcomes have also been
Autor:
Marta C. Nunes, Shabir A. Madhi
Publikováno v:
Expert Review of Vaccines. 10:951-980
Pneumococcal polysaccharide-protein conjugate vaccines (PCVs) generally protect against vaccine-serotype-specific pneumococcal disease. Additional serotypes included in the new 13-valent PCV (PCV-13) formulation and not in the first-generation 7-vale